Chemed Q3 revenue +7.2% to $565M; raises FY2023 adjusted EPS guidance to $19.82-$20.02

CHEMED CORP

2023-Q3 EPS reported $12.02 revenue$1,678,505,000

GAAP diluted EPS $4.93 (+30.4% YoY); adjusted diluted EPS $5.32 (+24.9%).
VITAS net patient revenue $334M (+12.5%), ADC 18,859 (+9.4%), adjusted EBITDA margin 16.5% (+441 bps).
Roto-Rooter revenue $231M (+0.4%), adjusted EBITDA $66.9M (-3.7%), margin 29.0% (-124 bps).
Full-year adjusted EPS guidance raised to $19.82-$20.02 from $18.72-$18.92, includes $1.18/sh retention costs.
Ended quarter with $173M cash, no debt; repurchased $14.3M in shares at avg $504.07.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

CHEMED CORP reported third quarter ended September 30, 2023 results: revenue $565 million, EPS $4.93. Guidance raised.

Period: third quarter ended September 30, 2023
Revenue: $565 million
EPS: $4.93
Guidance: raised
Result: reported results

Exact text from the filing

and after-tax expense for the Retention Program was $9.6 million and $7.1 million, respectively. Results for Quarter Ended September 30, 2023 · Revenue increased 7.2% to $565 million · GAAP Diluted Earnings-per-Share (EPS) of $4.93, an increase of 30.4% · Adjusted Diluted EPS of $5.32, an increase of 24.9% VITAS segment operating results: · Net Patient

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

CHEMED CORP updated its quarter ended September 30, 2023 guidance (raised).

Period: quarter ended September 30, 2023
Guidance: raised
Result: reported results

Exact text from the filing

On October 25, 2023, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2023.

View on SEC.gov

Browse all earnings releases →

CHEMED CORP filing history →

Source: SEC EDGAR

accession 0001562762-23-000378

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.